Julajak Limsrivilai1, Ryan W Stidham2, Shail M Govani3, Akbar K Waljee3, Wen Huang4, Peter D R Higgins5. 1. Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan; Division of Gastroenterology, Siriraj Hospital, Mahidol University, Bangkok, Thailand. 2. Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan. 3. Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan; VA Center for Clinical Management Research, VA Ann Arbor Health Care System, Ann Arbor, Michigan. 4. Medical Center Information Technology, University of Michigan, Ann Arbor, Michigan. 5. Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan. Electronic address: phiggins@med.umich.edu.
Abstract
BACKGROUND & AIMS: A subset of patients with inflammatory bowel diseases (IBD) have continuously active inflammation, leading to a high number of complications and high direct health care costs (diagnostic tests, medications, and surgeries) and indirect costs (reduced employment and productivity and fewer opportunities for activities). Identifying these high-risk patients and providing effective interventions could produce better outcomes and reduce costs. We used prior year data to create IBD risk models to predict IBD-related hospitalizations, emergency department visits, and high treatment charges (>$30,000/year) in the subsequent year. METHODS: We performed a retrospective study of medical records from all patients with IBD treated at the University of Michigan Hospital from fiscal years 2013-2015. We selected clinical variables from the prior year and tested their abilities to predict 3 adverse outcomes (IBD-related hospitalizations, emergency department visits, and treatment charges >$30,000/year) in the subsequent year. Individual patients were only included once in the data set. We created a multivariate model that was based on a 70% randomly selected cohort (1005 patients) and validated the model on the other 30% (425 patients). Logistic regression was used for bivariate and multivariate analyses. RESULTS: Factors that predicted high-cost outcomes included the presence of psychiatric illness, use of corticosteroids, use of narcotics, low levels of hemoglobin, and high numbers of IBD-related hospitalizations. In the validation cohort, the model predicted IBD-related hospitalizations, emergency department visits, and high charges in the following year with receiver operating characteristic curve values of 0.751, 0.738, and 0.744, respectively. CONCLUSIONS: We identified 5 factors that can effectively identify patients with IBD at high risk for hospitalization, emergency department visits, and high treatment charges in the next year. These patients should be closely monitored and aggressively managed.
BACKGROUND & AIMS: A subset of patients with inflammatory bowel diseases (IBD) have continuously active inflammation, leading to a high number of complications and high direct health care costs (diagnostic tests, medications, and surgeries) and indirect costs (reduced employment and productivity and fewer opportunities for activities). Identifying these high-risk patients and providing effective interventions could produce better outcomes and reduce costs. We used prior year data to create IBD risk models to predict IBD-related hospitalizations, emergency department visits, and high treatment charges (>$30,000/year) in the subsequent year. METHODS: We performed a retrospective study of medical records from all patients with IBD treated at the University of Michigan Hospital from fiscal years 2013-2015. We selected clinical variables from the prior year and tested their abilities to predict 3 adverse outcomes (IBD-related hospitalizations, emergency department visits, and treatment charges >$30,000/year) in the subsequent year. Individual patients were only included once in the data set. We created a multivariate model that was based on a 70% randomly selected cohort (1005 patients) and validated the model on the other 30% (425 patients). Logistic regression was used for bivariate and multivariate analyses. RESULTS: Factors that predicted high-cost outcomes included the presence of psychiatric illness, use of corticosteroids, use of narcotics, low levels of hemoglobin, and high numbers of IBD-related hospitalizations. In the validation cohort, the model predicted IBD-related hospitalizations, emergency department visits, and high charges in the following year with receiver operating characteristic curve values of 0.751, 0.738, and 0.744, respectively. CONCLUSIONS: We identified 5 factors that can effectively identify patients with IBD at high risk for hospitalization, emergency department visits, and high treatment charges in the next year. These patients should be closely monitored and aggressively managed.
Authors: Laura E Targownik; Zoann Nugent; Harminder Singh; Shawn Bugden; Charles N Bernstein Journal: Am J Gastroenterol Date: 2014-09-02 Impact factor: 10.864
Authors: Ioannis E Koutroubakis; Claudia Ramos-Rivers; Miguel Regueiro; Efstratios Koutroumpakis; Benjamin Click; Robert E Schoen; Jana G Hashash; Marc Schwartz; Jason Swoger; Leonard Baidoo; Arthur Barrie; Michael A Dunn; David G Binion Journal: Clin Gastroenterol Hepatol Date: 2015-04-08 Impact factor: 11.382
Authors: Michael D Kappelman; Sheryl L Rifas-Shiman; Carol Q Porter; Daniel A Ollendorf; Robert S Sandler; Joseph A Galanko; Jonathan A Finkelstein Journal: Gastroenterology Date: 2008-09-17 Impact factor: 22.682
Authors: Sunil Samuel; Steven B Ingle; Shamina Dhillon; Siddhant Yadav; W Scott Harmsen; Alan R Zinsmeister; William J Tremaine; William J Sandborn; Edward V Loftus Journal: Inflamm Bowel Dis Date: 2013-08 Impact factor: 5.325
Authors: Michael C Sulz; Uwe Siebert; Marjan Arvandi; Raffaella M Gothe; Johannes Wurm; Roland von Känel; Stephan R Vavricka; Christa Meyenberger; Markus Sagmeister Journal: Eur J Gastroenterol Hepatol Date: 2013-07 Impact factor: 2.566
Authors: Benjamin Click; Eric J Vargas; Alyce M Anderson; Siobhan Proksell; Ioannis E Koutroubakis; Claudia Ramos Rivers; Jana G Hashash; Miguel Regueiro; Andrew Watson; Michael A Dunn; Marc Schwartz; Jason Swoger; Leonard Baidoo; Arthur Barrie; David G Binion Journal: Inflamm Bowel Dis Date: 2015-10 Impact factor: 5.325
Authors: Davina Tribbick; Michael Salzberg; Maria Ftanou; William R Connell; Finlay Macrae; Michael A Kamm; Glen W Bates; Georgina Cunningham; David W Austin; Simon R Knowles Journal: Clin Exp Gastroenterol Date: 2015-07-17
Authors: Miguel Regueiro; Benjamin Click; Alyce Anderson; William Shrank; Jane Kogan; Sandra McAnallen; Eva Szigethy Journal: Clin Gastroenterol Hepatol Date: 2018-04-12 Impact factor: 11.382
Authors: Elyse R Thakur; Shubhada Sansgiry; Jennifer R Kramer; Akbar K Waljee; Jill K Gaidos; Linda A Feagins; Shail M Govani; Lilian Dindo; Hashem B El-Serag; Jason K Hou Journal: Inflamm Bowel Dis Date: 2020-08-20 Impact factor: 5.325
Authors: Charles N Bernstein; Lixia Zhang; Lisa M Lix; Lesley A Graff; John R Walker; John D Fisk; Scott B Patten; Carol A Hitchon; James M Bolton; Jitender Sareen; Renée El-Gabalawy; James Marriott; Ruth Ann Marrie Journal: Inflamm Bowel Dis Date: 2018-08-16 Impact factor: 5.325
Authors: Nisha B Shah; Jennifer Haydek; James Slaughter; Jonathan R Ashton; Autumn D Zuckerman; Rochelle Wong; Francesca Raffa; Ailish Garrett; Caroline Duley; Kim Annis; Julianne Wagnon; Lawrence Gaines; Robin Dalal; Elizabeth Scoville; Dawn B Beaulieu; David Schwartz; Sara N Horst Journal: Inflamm Bowel Dis Date: 2020-01-06 Impact factor: 5.325
Authors: Ruth Ann Marrie; Lesley A Graff; John D Fisk; Scott B Patten; Charles N Bernstein Journal: Inflamm Bowel Dis Date: 2021-07-27 Impact factor: 5.325